Atlas Trials

Bioequivalence of Xaroban 20mg (Rivaroxaban) Tablet and Xarelto 20mg (Rivaroxaban) Tablet Under Fed Conditions

Clinical trial NCT04689919 · COMPLETED

Trial details

NCT number
NCT04689919
Sponsor
University of Karachi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2022-02-19
Primary completion
2022-03-07
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.